Evidence map›Paper›PMID 30354370›Full record

ArticleCirculation. Cardiovascular quality and outcomes2018

What's in a Name? Factors That Influence the Usage of Generic Versus Trade Names for Cardiac Medications Among Healthcare Providers.

David Ouyang, Rebecca Tisdale, Paul Cheng, Jeffrey Chi, Jonathan H Chen, Euan Ashley

Abstract read
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David OuyangDivision of Cardiovascular Medicine (D.O., P.C., E.A.).
Rebecca TisdaleDivision of Hospital Medicine (R.T., J.C., J.H.C.), Department of Internal Medicine, Stanford University School of Medicine, CA.
Paul ChengDivision of Cardiovascular Medicine (D.O., P.C., E.A.).
Jeffrey ChiDivision of Hospital Medicine (R.T., J.C., J.H.C.), Department of Internal Medicine, Stanford University School of Medicine, CA.
Jonathan H ChenDivision of Hospital Medicine (R.T., J.C., J.H.C.), Department of Internal Medicine, Stanford University School of Medicine, CA.
Euan AshleyDivision of Cardiovascular Medicine (D.O., P.C., E.A.).

Funding

Data-Mining Clinical Decision Support from Electronic Health RecordsK01ES026837 · NIEHS · STANFORD UNIVERSITY · PI CHEN, JONATHAN H. · 2015 to 2019
$893k
The molecular mechanisms of SMAD3-mediated coronary disease riskF32HL143847 · NHLBI · STANFORD UNIVERSITY · PI CHENG, PAUL PO SHENG · 2018 to 2019
$114k
NHLBI NIH HHS F32 HL143847NIEHS NIH HHS K01 ES026837
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Attitude of Health PersonnelHealth Knowledge, Attitudes, PracticeTerminology as TopicBiasCardiovascular AgentsClinical Decision-MakingData MiningDrug PrescriptionsDrugs, GenericHumansPractice Patterns, Physicians'Text MessagingTherapeutic EquivalencyCardiovascular AgentsDrugs, Genericanthropology, medicalawarenessbiasdrug substitutionmedicinenames

Identifiers

PMID30354370
PMCPMC6497068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.